Accessibility Menu
 
Immage Biotherapeutics logo

Immage Biotherapeutics

(OTC) IMMG

Current Price$0.00
Market Cap$200
Since IPO (2015)-100%
5 Year-100%
1 Year+0%
1 Month+0%

Immage Biotherapeutics Financials at a Glance

Market Cap

$200

Revenue (TTM)

$0.00

Net Income (TTM)

$114.57K

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

12.50 (High)

Price

$0.00

Volume

500

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

IMMG News

No articles available.

IMMG: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Immage Biotherapeutics

Industry

Biotechnology

Headquarters

Bethesda, US

IMMG Financials

Key Financial Metrics (TTM)

Gross Margin

0%

Operating Margin

0%

Net Income Margin

0%

Return on Equity

0%

Return on Capital

-1%

Return on Assets

-89%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$200.00

Shares Outstanding

151.75M

Volume

500

Short Interest

0.00%

Avg. Volume

8.333

Financials (TTM)

Gross Profit

$8.53K

Operating Income

$216.48K

EBITDA

$207.95K

Operating Cash Flow

$215.82K

Capital Expenditure

$0.00

Free Cash Flow

$215.82K

Cash & ST Invst.

$196.72K

Total Debt

$52.77K

Immage Biotherapeutics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name
Q1 2017YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$200.00

N/A

Market Cap/Employee

$66.67

N/A

Employees

3

N/A

Net Income

$44.09

+99.9%

EBITDA

$41.96K

+37.6%

Quarterly Fundamentals

Name
Q1 2017YOY CHG

Net Cash

$53.69K

-83.6%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$0.00

N/A

Return on Assets

-89.05%

N/A

Return on Invested Capital

-1.16%

N/A

Free Cash Flow

$71.95K

-21.5%

Operating Cash Flow

$71.95K

-21.5%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
CHFIChina Finance, Inc.
$0.00+0.00%
BLPFFBLOK Technologies Inc.
$0.00+0.00%
EURIAgriEuro Corp.
$0.00+0.00%
CIVXCTR Investments & Consulting, Inc.
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
UGROUrban-gro
$6.15+1.82%
TQQQProShares Trust - ProShares UltraPro Qqq
$44.57+0.03%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$12.95+0.07%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$7.58-0.03%

Questions About IMMG

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.